This is unpublished

Telebuprenorphine Quarterly Summary

Q4 2025 dashboard: 1,872 calls (3% increase), 372 telehealth visits (12% increase), 370 prescriptions (12% increase), 192 linked to care (16% increase).
This dashboard presents the Telebuprenorphine Quarterly Summary for Q4 2025.

Telebuprenorphine Program History

Program history: 9,518 total calls, 2180 total telehealth visits, 1,962 total prescriptions written, 987 total patients linked to care.
This dashboard presents the Telebuprenorphine Program History with cumulative totals across all quarters.

Call Center Metrics - Q4 2025

Q4 2025 call metrics: 1,872 incoming calls, 386 seeking Rx, 2,688 texts exchanged, 3 avg contact attempts, 1,235 total contacts made.
This dashboard presents Call Center Metrics for Q4 2025.

Patient Outcomes - Q4 2025

Q4 2025 outcomes: 372 telehealth visits, 369 OUD diagnoses, 370 prescriptions, 369 LTCC referrals, 10 high-risk patients, 89% pickup rate.
This dashboard presents Patient Outcomes for Q4 2025.

Data Dictionary

Definitions of key program metrics including calls, prescriptions, linkage to care, high-risk patients, and referral types.
This dashboard presents a Data Dictionary defining key metrics.

2024 

  • 3,534 calls taken 
  • 909 telehealth visits 
  • 654 patients